Wounds and Injuries
Welcome,         Profile    Billing    Logout  
 125 Companies   160 Products   160 Products   105 Mechanisms of Action   13 Trials   4683 News 


«12...678910111213141516...9394»
  • ||||||||||  Phase classification:  tDCS in MCS: Repeated Stimulations (clinicaltrials.gov) -  Mar 31, 2017   
    P=N/A,  N=20, Completed, 
    Completed --> Terminated; The study was terminated because of lack of funding. Phase classification: P2 --> P=N/A
  • ||||||||||  Enrollment change:  VROT: Virtual Reality Pain Control Orthopedic Trauma (clinicaltrials.gov) -  Mar 30, 2017   
    P=N/A,  N=300, Recruiting, 
    Phase classification: P2 --> P=N/A N=100 --> 300
  • ||||||||||  tranexamic acid oral / Generic mfg.
    Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date:  The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures (clinicaltrials.gov) -  Mar 27, 2017   
    P4,  N=0, Withdrawn, 
    N=132 --> 32 | Suspended --> Terminated N=150 --> 0 | Initiation date: Aug 2014 --> Dec 2015 | Recruiting --> Withdrawn | Trial primary completion date: Aug 2016 --> Dec 2018
  • ||||||||||  Trial termination:  I-TRIGER: INR-Triggered Transfusion In GI Bleeders From ER (clinicaltrials.gov) -  Mar 27, 2017   
    P3,  N=50, Terminated, 
    Trial primary completion date: Dec 2016 --> Dec 2017 Active, not recruiting --> Terminated
  • ||||||||||  Enrollment closed, Trial primary completion date:  Safety Study of Ibuprofen to Treat Acute Traumatic Spinal Cord Injury (clinicaltrials.gov) -  Mar 23, 2017   
    P1,  N=12, Active, not recruiting, 
    Active, not recruiting --> Terminated Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Sep 2017
  • ||||||||||  Trial completion, Trial primary completion date:  SpineTRACK Registry - Spinal Outcomes Registry (clinicaltrials.gov) -  Mar 23, 2017   
    P=N/A,  N=10000, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Sep 2017 Enrolling by invitation --> Completed | Trial primary completion date: Dec 2023 --> Dec 2016
  • ||||||||||  Phase classification, Enrollment change, Trial initiation date, Trial termination, Trial primary completion date:  D2D: Vitamin D 2 to Dialysis Patients (clinicaltrials.gov) -  Mar 15, 2017   
    P=N/A,  N=18, Terminated, 
    Trial primary completion date: Apr 2016 --> Apr 2017 Phase classification: P4 --> P=N/A | N=200 --> 18 | Initiation date: Sep 2010 --> Jun 2008 | Not yet recruiting --> Terminated | Trial primary completion date: Sep 2011 --> Jun 2009; Because of departure of study personnel and lack of funding
  • ||||||||||  Phase classification:  The Teachable Moment: Screening and Brief Intervention for Admitted Trauma Patients (clinicaltrials.gov) -  Mar 14, 2017   
    P=N/A,  N=333, Completed, 
    Phase classification: P4 --> P=N/A | N=200 --> 18 | Initiation date: Sep 2010 --> Jun 2008 | Not yet recruiting --> Terminated | Trial primary completion date: Sep 2011 --> Jun 2009; Because of departure of study personnel and lack of funding Phase classification: P2 --> P=N/A
  • ||||||||||  Trial primary completion date:  Subsymptom Threshold Exercise Protocol Following Mild TBI (clinicaltrials.gov) -  Mar 14, 2017   
    P=N/A,  N=40, Recruiting, 
    Phase classification: P2 --> P=N/A Trial primary completion date: Dec 2016 --> Jun 2017
  • ||||||||||  Enrollment change, Trial initiation date, Trial primary completion date:  A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in Morocco (clinicaltrials.gov) -  Mar 13, 2017   
    P2/3,  N=60, Not yet recruiting, 
    Active, not recruiting --> Completed N=30 --> 60 | Initiation date: Jul 2012 --> Jun 2017 | Trial primary completion date: Oct 2012 --> Mar 2018
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Cardiovascular, Cerebrovascular, and Cognitive Function in Spinal Cord Injury (clinicaltrials.gov) -  Mar 10, 2017   
    P=N/A,  N=61, Active, not recruiting, 
    Active, not recruiting --> Completed | Initiation date: Jan 2013 --> Oct 2013 Recruiting --> Active, not recruiting | N=130 --> 61 | Trial primary completion date: Aug 2016 --> Jan 2017
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Repair of Medial Patellofemoral Ligament Compared to Conservative Treatment for First Time Patella Dislocation (clinicaltrials.gov) -  Mar 9, 2017   
    P=N/A,  N=2, Terminated, 
    Recruiting --> Active, not recruiting | N=130 --> 61 | Trial primary completion date: Aug 2016 --> Jan 2017 N=40 --> 2 | Recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Mar 2016; Inadequate patient recruitment and coordinator left organization
  • ||||||||||  Phase classification, Trial primary completion date:  Open Reduction Syndesmosis Tightrope Versus Screw Fixation (clinicaltrials.gov) -  Mar 8, 2017   
    P=N/A,  N=72, Recruiting, 
    N=40 --> 2 | Recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Mar 2016; Inadequate patient recruitment and coordinator left organization Phase classification: P4 --> P=N/A | Trial primary completion date: Sep 2016 --> Sep 2017
  • ||||||||||  Flector (diclofenac epolamine) / IBSA Institute Biochemical SA
    Enrollment closed, Trial primary completion date:  Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries (clinicaltrials.gov) -  Mar 7, 2017   
    P4,  N=104, Active, not recruiting, 
    N=60 --> 110 | Trial primary completion date: Jul 2016 --> Jul 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Oct 2016
  • ||||||||||  tranexamic acid oral / Generic mfg.
    Enrollment closed, Trial primary completion date:  Prehospital Tranexamic Acid Use for Traumatic Brain Injury (clinicaltrials.gov) -  Mar 7, 2017   
    P2,  N=967, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Oct 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Oct 2017
  • ||||||||||  oxytocin / Generic mfg.
    Trial completion, Trial primary completion date:  FOLCROM Trial: Foley Catheter in Rupture of Membranes (clinicaltrials.gov) -  Mar 7, 2017   
    P=N/A,  N=201, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Oct 2017 Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jul 2016
  • ||||||||||  Trial completion, Trial primary completion date:  A Study to Assess the Long-term Performance of SmartSet (clinicaltrials.gov) -  Mar 3, 2017   
    P4,  N=243, Completed, 
    Trial primary completion date: Jun 2016 --> Sep 2018 Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jul 2016
  • ||||||||||  prazosin / Generic mfg.
    Trial completion, Trial primary completion date:  Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=7, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jul 2016 Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Jul 2011
  • ||||||||||  ropivacaine / Generic mfg., epinephrine / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Femoral Nerve Block for Femur Fracture Repair in Pediatrics (clinicaltrials.gov) -  Mar 3, 2017   
    P2,  N=19, Terminated, 
    Trial primary completion date: Dec 2016 --> May 2017 N=40 --> 19 | Enrolling by invitation --> Terminated | Trial primary completion date: Dec 2017 --> Oct 2016; Interim analysis showed no significant difference between study arms.
  • ||||||||||  Phase classification, Head-to-Head:  Written Exposure Therapy for Posttraumatic Stress Disorder (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=126, Active, not recruiting, 
    N=40 --> 19 | Enrolling by invitation --> Terminated | Trial primary completion date: Dec 2017 --> Oct 2016; Interim analysis showed no significant difference between study arms. Phase classification: P2 --> P=N/A
  • ||||||||||  Trial completion, Phase classification:  ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=87, Completed, 
    Recruiting --> Completed | N=10 --> 37 | Trial primary completion date: Oct 2011 --> Dec 2012 Active, not recruiting --> Completed | Phase classification: P1 --> PN/A
  • ||||||||||  Trial completion, Enrollment change:  Vitamin D Deficiency and Replacement on Pulmonary and Endocrine Function in SCI (clinicaltrials.gov) -  Mar 3, 2017   
    P1/2,  N=88, Completed, 
    Active, not recruiting --> Suspended | Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | N=300 --> 88
  • ||||||||||  Trial completion, Enrollment change:  IR and Microvascular Blood Flow in SCI (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=68, Completed, 
    Recruiting --> Completed | N=300 --> 88 Recruiting --> Completed | N=160 --> 68
  • ||||||||||  Trial completion, Trial primary completion date:  Microfinance Intervention to Improve Health of Trauma Survivors in DRC (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=878, Completed, 
    Recruiting --> Completed | N=160 --> 68 Active, not recruiting --> Completed | Trial primary completion date: Apr 2016 --> Sep 2016
  • ||||||||||  atorvastatin / Generic mfg.
    Trial completion, Enrollment change, Surgery:  POST-OP Pilot: Pilot Study of Atorvastatin for Orthopedic Surgery Patients (clinicaltrials.gov) -  Mar 1, 2017   
    P2,  N=20, Completed, 
    Active, not recruiting --> Completed | N=10 --> 3 Recruiting --> Completed | N=30 --> 20
  • ||||||||||  Trial primary completion date:  Insole Sensor to Determine Optimal Limb Loading (clinicaltrials.gov) -  Feb 27, 2017   
    P=N/A,  N=50, Enrolling by invitation, 
    Trial primary completion date: Aug 2017 --> Aug 2018 Trial primary completion date: Jun 2017 --> Jun 2018